Effects of oral ATP supplementation on anaerobic power and muscular strength

Medicine and Science in Sports and Exercise

Volumn 36, Issue 6, 2004, Pages 983-990

  Jordan, Alexander N ^a   Jurca, Radim ^a   Abraham, Edward H ^b   Salikhova, Anna ^b   Mann, Julia K ^a   Morss, Gina M ^a   Church, Timothy S ^a   Lucia, Alejandro ^c   Earnest, Conrad P ^a  

^a Ctr for Hum Perf and Nutr Res ^*  (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c UNIVERSIDAD EUROPEA DE MADRID   (Spain)

Author keywords

Adenosine; Anaerobic performance; Metabolism; Nutrition

Indexed keywords

ADENOSINE TRIPHOSPHATE; LACTIC ACID; PLACEBO;

ADULT; ANAEROBIC CAPACITY; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; ENTERIC COATED TABLET; FATIGUE; HUMAN; HUMAN EXPERIMENT; MALE; METABOLISM; MUSCLE STRENGTH; NORMAL HUMAN; NUTRITION; PARAMETER; PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; UNITED STATES; WORK CAPACITY;

ADENOSINE TRIPHOSPHATE; ADMINISTRATION, ORAL; ANAEROBIC THRESHOLD; EXERCISE; HUMANS; MUSCLE, SKELETAL;

EID: 2642557197     PISSN: 01959131     EISSN: None     Source Type: Journal    
DOI: 10.1249/01.MSS.0000128198.97260.8B     Document Type: Article

References (36)

1. ABRAHAM, E. H., A. Y. SALIKHOVA, and E. B. HUG. Critical ATP parameters associated with blood and mammalian cells: relevant measurement techniques. Drug Dev. Res. 59:160, 2003.
2. AGTERESCH, H. J., P. C. DAGNELIE, J. W. VAN DEN BERG, et al. Adenosine triphosphate: established and potential clinical applications. Drugs 58:211-232, 1999.
3. AHLIJANIAN, M. K., and A. E. TAKEMORI. The effect of chronic administration of caffeine on morphine-induced analgesia, tolerance and dependence in mice. Eur. J. Pharmacol. 120:25-32, 1986.
4. BAR-OR, O. The Wingate anaerobic test: an update on methodology, reliability and validity. Sports Med. 4:381-394, 1987.
5. BENNETT, G. C., and M. R. BOARDER. The effect of nucleotides and adenosine on stimulus-evoked glutamate release from rat brain cortical slices. Br. J. Pharmacol. 131:617-623, 2000.
6. BIRCH, R., D. NOBLE, and P. L. GREENHAFF. The influence of dietary creatine supplementation on performance during repeated bouts of maximal isokinetic cycling in man. Eur. J. Appl. Physiol. Occup. Physiol. 69:268-276, 1994.
7. CHOCA, J. I., R. D. GREEN, and H. K. PROUDFIT. Adenosine A1 and A2 receptors of the substantia gelatinosa are located predominantly on intrinsic neurons: an autoradiography study. J. Pharmacol. Exp. Ther. 247:757-764, 1988.
8. CHOCA, J. I., H. K. PROUDFIT, and R. D. GREEN. Identification of A1 and A2 adenosine receptors in the rat spinal cord. J. Pharmacol. Exp. Ther. 242:905-910, 1987.
9. DOAN, B. K., R. U. NEWTON, J. L. MARSIT, et al. Effects of increased eccentric loading on bench press 1RM. J. Strength Cond. Res. 16:9-13, 2002.
10. DOTAN, R., and O. BAR-OR. Load optimization for the Wingate Anaerobic Test. Eur. J. Appl. Physiol. Occup. Physiol. 51:409-417, 1983.
11. DUNWIDDIE, T. V., and S. A. MASINO. The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci. 24:31-55, 2001.
12. GEIGER, J. D., F. S. LABELLA, and J. I. NAGY. Characterization and localization of adenosine receptors in rat spinal cord. J. Neurosci. 4:2303-2310, 1984.
13. GREEN, A. L., E. HULTMAN, I. A. MACDONALD, et al. Carbohydrate ingestion augments skeletal muscle creatine accumulation during creatine supplementation in humans. Am. J. Physiol. 271:E821-E826, 1996.
14. GREEN, A. L., E. J. SIMPSON, J. J. LITTLEWOOD, et al. Carbohydrate ingestion augments creatine retention during creatine feeding in humans. Acta Physiol. Scand. 158:195-202, 1996.
15. GREENHAFF, P. L. Creatine and its application as an ergogenic aid. Int. J. Sport Nutr. 5(Suppl.):S100-S110, 1995.
16. GREENHAFF, P. L., A. CASEY, A. H. SHORT, et al. Influence of oral creatine supplementation of muscle torque during repeated bouts of maximal voluntary exercise in man. Clin. Sci. (Lond.) 84:565-571, 1993.
17. HULTMAN, E., K. SODERLUND, J. A. TIMMONS, et al. Muscle creatine loading in men. J. Appl. Physiol. 81:232-237, 1996.
18. KHAKH, B. S., and G. HENDERSON. ATP receptor-mediated enhancement of fast excitatory neurotransmitter release in the brain. Mol. Pharmacol. 54:372-378, 1998.
19. KICHENIN, K., S. DECOLLOGNE, J. ANGIGNARD, et al. Cardiovascular and pulmonary response to oral administration of ATP in rabbits. J. Appl. Physiol. 88:1962-1968, 2000.
20. KICHENIN, K., and M. SEMAN. Chronic oral administration of ATP modulates nucleoside transport and purine metabolism in rats. J. Pharmacol. Exp. Ther. 294:126-133, 2000.
21. KOCH, H., I. KUGELGEN, and K. STARKE. P2-receptor-mediated inhibition of noradrenaline release in the rat hippocampus. Naunyn Schmiedebergs Arch. Pharmacol. 355:707-715, 1997.
22. KRUGEL, U., H. KITTNER, and P. ILLES. Adenosine 5′ -triphosphate-induced dopamine release in the rat nucleus accumbens in vivo. Neurosci. Lett. 265:49-52, 1999.
23. MERCADANTE, S., R. SERRETTA, and A. CASUCCIO. Effects of caffeine as an adjuvant to morphine in advanced cancer patients: a randomized, double-blind, placebo-controlled, crossover study. J. Pain Symptom Manage. 21:369-372, 2001.
24. MOHAMEDALI, K. A., O. M. GUICHERIT, R. E. KELLEMS, et al. The highest levels of purine catabolic enzymes in mice are present in the proximal small intestine. J. Biol. Chem. 268:23728-23733, 1993.
25. MOSER, G. H., J. SCHRADER, and A. DEUSSEN. Turnover of adenosine in plasma of human and dog blood. Am. J. Physiol. 256: C799-C806, 1989.
26. NEWSHOLME, E. A. Basic aspects of metabolic regulation and their application to provision of energy in exercise. In: Principles of Exercise Biochemistry, J. R. Poormans (Ed.). Basel: Karger, 1993, pp. 52-88.
27. RAMKUMAR, V., Z. NIE, L. P. RYBAK, et al. Adenosine, antioxidant enzymes and cytoprotection. Trends Pharmacol. Sci. 16:283-285, 1995.
28. RAPAPORT, E., and J. FONTAINE. Anticancer activities of adenine nucleotides in mice are mediated through expansion of erythrocyte ATP pools. Proc. Natl. Acad. Sci. USA 86:1662-1666, 1989.
29. SAHLIN, K. Metabolic changes limiting muscle performance. In: Biochemistry of Exercise, B. Saltin (Ed.). Champaign, IL: Human Kinetics, 1986, pp. 323-343.
30. SALTER, M. W., and J. L. HENRY. Effects of adenosine 5′ -monophosphate and adenosine 5′-triphosphate on functionally identified units in the cat spinal dorsal horn: evidence for a differential effect of adenosine 5′-triphosphate on nociceptive vs non-nociceptive units. Neuroscience 15:815-825, 1985.
31. SAWYNOK, J., and M. I. SWEENEY. The role of purines in nociception. Neuroscience 32:557-569, 1989.
32. SAWYNOK, J., M. I. SWEENEY, and T. D. WHITE. Adenosine release may mediate spinal analgesia by morphine. Trends Pharmacol. Sci. 10: 186-189, 1989.
33. SHRYOCK, J. C., and L. BELARDINELLI. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am. J. Cardiol. 79:2-10, 1997.
34. STEENGE, G. R., E. J. SIMPSON, and P. L. GREENHAFF. Protein- and carbohydrate-induced augmentation of whole body creatine retention in humans. J. Appl. Physiol. 89:1165-1171, 2000.
35. TRENDELENBURG, A. U., and R. BULTMANN. P2 receptor-mediated inhibition of dopamine release in rat neostriatum. Neuroscience 96:249-252, 2000.
36. WEINSTEIN, Y., C. BEDIZ, R. DOTAN, et al. Reliability of peak-lactate, heart rate, and plasma volume following the Wingate test. Med. Sci. Sports Exerc. 30:1456-1460, 1998.